Low-dose nivolumab plus avd shows high response rate at a lower cost in hl Oncology Nurse Advisor 2d Oncology Nurse Advisor 2d
Middle East presence strengthened with potential blood cancer treatment, generated by AI, first of its kind in the... ecancer 2d ecancer 2d
Gene that drives blood cancer drug resistance uncovered with new CRISPR activation tool ecancer 3d ecancer 3d
EVITA clinical trial evaluates oral vitamin C for pre-cancerous blood disorders News-Medical.Net 3d News-Medical.Net 3d
Pepaxti gains positive CHMP opinion for third-line multiple myeloma treatment Manufacturing Chemist 3d Manufacturing Chemist 3d
Johnson & Johnson's Tecvayli-Darzalex Combo Shows Long-Term Survival Potential RTT News 16:38 Wed, 23 Sep
Low-Dose Nivolumab Plus AVD Shows High Response Rate at a Lower Cost in HL Oncology Nurse Advisor 14:08 Tue, 22 Sep
Middle East presence strengthened with potential blood cancer treatment, generated by AI, first of its kind in the... ecancer 10:58 Tue, 22 Sep
EVITA clinical trial evaluates oral vitamin C for pre-cancerous blood disorders News-Medical.Net 15:35 Mon, 21 Sep
Pepaxti gains positive CHMP opinion for third-line multiple myeloma treatment Manufacturing Chemist 14:44 Mon, 21 Sep
Gene that drives blood cancer drug resistance uncovered with new CRISPR activation tool ecancer 12:21 Mon, 21 Sep